Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:783709.
doi: 10.1155/2015/783709. Epub 2015 Sep 29.

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study

A Emamifar  1 , Rannveig Gildberg-Mortensen  1 , S Andreas Just  1 , N Lomborg  1 , R Asmussen Andreasen  1 , I M Jensen Hansen  1
Affiliations

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study

A Emamifar et al. Int J Rheumatol. 2015.

Abstract

Objective. To estimate level of adherence to oral calcium and vitamin D supplementation as well as bisphosphonate amongst patients with PMR and GCA treated with glucocorticoids. Method. A total of 138 patients with the diagnosis of PMR and/or GCA registered in our department in December 2013. In this cross-sectional study we interviewed all the patients to measure level of adherence to calcium and vitamin D, as well as bisphosphonates. Results. Out of the 118 included patients, 88.9% of them were adherent to their prescription. Only 2 patients (1.7%) did not take calcium and vitamin D at all and 10 patients (8.5%) took their medication infrequently, 9 and 1 out of 10 patients took the medication 50-100% of the time and less than 50% of the prescribed dose, respectively. Sixty-one patients received additional treatment with bisphosphonate and 96.6% were adherent to this therapy. The remaining 3.4% of the patients did not take the medication at all. Forgetfulness, adverse side effects, and lack of understanding of treatment benefits were the most significant causes for nonadherence to calcium and vitamin D. Conclusions. Contrary to what we expected this study found that adherence to osteoporosis preventive medication in patients with PMR and GCA was high.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients included in the study.
Figure 2
Figure 2
Level of adherence to Ca, vitamin D supplements, and bisphosphonates amongst PMR/GCA patients.
Figure 3
Figure 3
The most important causes of nonadherence amongst PMR/GCA patients.
See this image and copyright information in PMC

References

    1. Caylor T. L., Perkins A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. American Family Physician. 2013;88(10):676–684. - PubMed
    1. Unwin B., Williams C. M., Gilliland W. Polymyalgia rheumatica and giant cell arteritis. American Family Physician. 2006;74(9):1547–1557. - PubMed
    1. Lindberg M., Hoerslev-Petersen K. National Danish Guideline for Diagnosis and Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis. 2008. http://www.danskreumatologiskselskab.dk/fileadmin/DRS/kliniskeretningsli....
    1. Duru N., van der Goes M. C., Jacobs J. W. G., et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases. 2013;72(12):1905–1913. doi: 10.1136/annrheumdis-2013-203249. - DOI - PubMed
    1. Grossman J. M., Gordon R., Ranganath V. K., et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care & Research. 2010;62(11):1515–1526. doi: 10.1002/acr.20295. - DOI - PubMed

LinkOut - more resources